The Journal of Organic Chemistry
Article
mL) and MeOH (30 mL), and then NaBH4 (0.38 g, 10.0 mmol) was
added in portions. After stirring overnight, the solvents were removed
under vacuum, and the residue was extracted by CH2Cl2. The organic
layer was washed by brine until clear, dried over anhydrous Na2SO4,
removed of solvent under reduced pressure, and purified on a silica gel
column using petroleum ether/ethyl acetate (2:1) as the eluent to
obtain the compound 27 as a light-yellow solid. Yield: 0.72 g, 65%.
Compound 27: 1H NMR (400 MHz, CDCl3): δ ppm = 8.26−8.22 (m,
6H), 8.10−8.08 (m, 4H), 8.05−7.99 (m, 6H), 6.80 (s, 3H), 6.63 (s,
2H), 6.54 (s, 3H), 6.51 (s, 2H), 6.36 (s, 2H), 5.71 (s, 4H), 4.95 (s,
4H), 3.80−3.78 (m, 4H), 3.72 (s, 12H), 1.58 (s, 18H). 13C NMR (100
MHz, CDCl3): δ ppm = 161.0, 160.9, 160.3, 160.0, 159.9, 149.1, 139.3,
139.2, 131.3, 129.0, 127.1, 122.8, 122.5, 122.5, 107.6, 107.4, 107.2,
105.3, 105.2, 100.0, 70.1, 68.9, 55.2, 53.2, 35.1, 31.8. ESI MS: m/z =
1102.50 [M + H+]; calculated exact mass: 1101.52. Anal. Calcd for
C74H71NO8: C, 80.63; H, 6.49; N, 1.27. Found: C, 80.50; H, 6.42; N,
1.36.
5H), 6.54 (d, J = 1.8 Hz, 2H), 6.50 (d, J = 7.8 Hz, 2H), 6.46 (s, 1H),
6.44 (s, 2H), 6.42 (s, 2H), 6.40 (d, J = 1.8 Hz, 6H), 6.32 (br, 3H), 6.11
(d, J = 1.8 Hz, 3H), 5.00 (s, 2H), 4.54 (br, 5H), 4.46 (br, 3H), 4.02 (s,
2H), 3.92−3.90 (m, 6H), 3.84−3.83 (m 3H), 3.75 (br, 7H), 3.73 (br,
5H), 3.72 (s, 4H), 3.70 (s, 18H), 3.64−3.63 (m, 3H), 1.68 (t, J = 7.2,
2H), 1.30 (br, 22H), 0.89 (t, J = 6.6 Hz, 3H). 13C NMR (100 MHz,
CD3CN): δ ppm = 161.6, 160.2, 147.3, 139.8, 137.3, 135.0, 121.8,
112.7, 110.5, 109.2, 108.8, 108.1, 105.9, 105.5, 104.1, 99.9, 99.2, 71.7,
71.0, 70.1, 69.5, 67.9, 55.5, 53.0, 50.1, 32.3, 30.0, 29.7, 29.1, 26.1, 23.0,
−
14.1. ESI MS: m/z = 1555.50 [M − PF6 ]; calculated exact mass:
1698.80. Anal. Calcd for C91H117F6N4O18P: C, 64.30; H, 6.94; N, 3.30.
Found: C, 64.39; H, 6.87; N, 3.23.
Synthesis of 3a. The synthesis procedure of 3a was similar to the
1
synthesis of 1b. Yield: 0.19 g, 72%. Compound 3a: H NMR (600
MHz, CD3CN): δ ppm = 8.92 (s, 2H), 7.52 (t, J = 7.8 Hz, 1H), 7.14
(d, J = 7.8 Hz, 2H), 6.59 (br, 3H), 6.54 (br, 11H), 6.52 (s, 2H), 6.50
(s, 2H), 6.48 (s, 3H), 6.46 (s, 1H), 6.44 (br, 11H), 6.41−6.40 (m,
7H), 6.37 (s, 2H), 6.32 (br, 3H), 6.21 (d, J = 7.2 Hz, 2H), 6.03 (br,
3H), 4.90 (s, 1H), 4.88 (br, 9H), 4.86 (br, 3H), 4.83 (s, 1H), 4.78 (s,
2H), 4.75 (s, 3H), 4.70 (s, 1H), 4.52 (br, 5H), 4.41 (br, 3H), 4.05 (s,
2H), 3.86 (br, 3H), 3.79 (br, 3H), 3.71 (br, 28H), 3.68 (br, 12H), 3.65
(br, 5H), 3.61 (br, 14H). 13C NMR (100 MHz, CD3CN): δ ppm =
161.9, 161.8, 160.7, 160.6, 147.6, 140.3, 140.2, 137.4, 135.1, 122.1,
110.9, 110.0, 108.6, 107.3, 107.2, 107.1, 106.2, 104.1, 102.2, 101.7,
100.1, 70.3, 69.9, 55.8, 55.7, 32.0, 23.1, 14.1. MALDI MS: m/z =
Synthesis of 5d. 27 (1.10 g, 1.0 mmol) was dissolved in acetone
(200 mL) and treated sequentially with HCl (aq) (1 M, 2 mL) and
saturated NH4PF6 (aq) (20 mL). The organic solvent was evaporated
under reduced pressure; the precipitate was filtered off and washed
with water (10 mL) for several times to afford 5d as a yellow solid.
1
Yield: 1.10 g, 88%. Compound 5d: H NMR (400 MHz, CDCl3): δ
ppm = 8.15 (d, J = 8.8 Hz, 6H), 8.00−7.87 (m, 10H), 6.75 − 6.73 (m,
2H), 6.54 (s, 2H), 6.51 (s, 2H), 6.47 (s, 4H), 6.28 (s, 2H), 5.59 (s,
4H), 4.88 (s, 4H), 3.83 (s, 4H), 3.63 (s, 12H), 1.55 (s, 18H). 13C
NMR (100 MHz, CDCl3): δ ppm = 160.8, 160.5, 160.2, 149.0, 138.8,
138.7, 131.1, 130.9, 130.4, 128.9, 128.8, 122.7, 122.5, 108.6, 108.3,
105.1, 99.8, 69.8, 68.7, 55.1, 35.1, 31.8, 29.7. ESI MS: m/z = 1102.80
−
2430.25 [M − PF6 ]; calculated exact mass: 2575.01. Anal. Calcd for
C141H153F6N4O33P: C, 65.72; H, 5.98; N, 2.17. Found: C, 65.66; H,
5.84; N, 2.25.
Synthesis of 3b. The synthesis procedure of 3b was similar to the
−
1
[M − PF6 ]; calculated exact mass: 1247.50. Anal. Calcd for
synthesis of 1b. Yield: 0.20 g, 71%. Compound 3b: H NMR (600
C74H72F6NO8P: C, 71.20; H, 5.81; N, 1.12. Found: C, 71.09; H,
5.73; N, 1.21.
MHz, CD3CN): δ ppm = 8.88 (s, 2H), 6.73 (s, 1H), 6.57 (br, 4H),
6.53 (br, 9H), 6.49 (br, 9H), 6.45 (br, 7H), 6.43 (br, 5H), 6.40 (br,
6H), 6.36 (br, 5H), 6.32 (br, 3H), 6.06 (s, 3H), 4.87 (br, 8H), 4.84
(br, 10H), 4.73 (s, 3H), 4.47 (s, 4H), 4.42 (br, 3H), 4.02 (s, 2H), 3.84
(s, 2H), 3.78−3.76 (m, 3H), 3.71−3.70 (m, 22H), 3.67−3.66 (m,
32H), 3.61 (d, J = 1.8 Hz, 9H), 1.44 (s, 2H), 1.24−0.89 (m, 22H),
0.85 (t, J = 7.2 Hz, 3H). 13C NMR (100 MHz, CD3CN): δ ppm =
161.8, 161.8, 161.4, 160.7, 160.5, 147.5, 140.5, 140.3, 140.3, 140.1,
137.5, 135.2, 113.0, 108.5, 107.3, 107.0, 106.1, 102.2, 101.7, 100.2,
100.1, 71.9, 71.1, 71.0, 70.3, 69.9, 69.3, 68.2, 55.7, 55.7, 53.2, 52.8,
50.4, 32.4, 30.2, 29.8, 26.3, 23.1, 14.2. MALDI MS: m/z = 2642.39 [M
− PF6−]; calculated exact mass: 2787.22. Anal. Calcd for
C155H181F6N4O34P: C, 66.75; H, 6.54; N, 2.01. Found: C, 66.65; H,
6.59; N, 2.12.
Synthesis of 1b. A mixture of salt 5a (93 mg, 0.2 mmol),
tetraethylene glycol bis(2-aminophenyl)ether 7 (75 mg, 0.2 mmol),
and 2,6-pyridinedicarboxaldehyde derivative 6b (69 mg, 0.2 mmol)
was stirred for 24 h in dry CH3CN (10 mL) under argon atmosphere
at room temperature. Then 1 M BH3·THF solution (1.6 mL) was
added, and the mixture was further stirred overnight. The solvents
were removed under vacuum, and the residue was purified by column
chromatography (silica gel, CH2Cl2/MeCN/MeOH = 100:0:0−
75:25:1) to give the [2]rotaxane 1b. Yield: 0.20 g, 85%. Compound
1
1b: H NMR (600 MHz, CD3CN): δ ppm = 8.80 (s, 2H), 6.95 (s,
2H), 6.70−6.64 (m, 4H), 6.61−6.60 (m, 2H), 6.45 (d, J = 7.2 Hz,
2H), 6.27 (s, 2H), 6.14 (s, 4H), 4.52 (br, 4H), 4.41 (s, 2H), 4.15−4.13
(m, 2H), 4.04 (s, 4H), 3.92 (d, J = 3.0 Hz, 4H), 3.83 (s, 4H), 3.77 (s,
2H), 3.75 (s, 4H), 3.42 (s, 12H), 1.82 (t, J = 5.4 Hz, 2H), 1.49 (br,
2H), 1.40 (br, 2H), 1.29 (br, 18H), 0.89 (m, 3H). 13C NMR (100
MHz, CD3CN): δ ppm = 161.5, 147.2, 137.6, 134.7, 122.0, 120.0,
112.9, 110.8, 109.4, 108.4, 108.1, 107.3, 101.4, 71.6, 71.0, 70.7, 69.9,
68.1, 55.6, 53.2, 50.1, 32.3, 30.0, 29.7, 29.1, 26.2, 23.0, 14.1. ESI MS:
Synthesis of 4a. A mixture of 5d (125 mg, 0.1 mmol),
tetraethylene glycol bis(2-aminophenyl)ether 7 (38 mg, 0.1 mmol),
and 2,6-pyridinedicarboxaldehyde 6a (14 mg, 0.1 mmol) were stirred
for 24 h in dry CH3NO2 (20 mL) under argon atmosphere at room
temperature. Then 1 M BH3·THF solution (0.8 mL) was added, and
the mixture was further stirred overnight. The solvents were removed
under vacuum, and the residue was purified by column chromatog-
raphy (silica gel, CH2Cl2/MeCN/MeOH = 100:0:0−75:25:1) to give
the [2]rotaxane 4a. Yield: 36 mg, 21%. Compound 4a: 1H NMR (600
MHz, CDCl3): δ ppm = 9.08 (s, 2H), 8.20 (d, J = 12.6 Hz, 4H), 7.99
(s, 6H), 7.92 (d, J = 7.8 Hz, 2H), 7.88 (d, J = 9.0 Hz, 2H), 7.71 (d, J =
7.8 Hz, 2H), 7.53 (t, J = 7.2 Hz, 1H), 7.02 (d, J = 7.2 Hz, 2H), 6.75 (s,
1H), 6.52 (t, J = 6.6 Hz, 3H), 6.41 (d, J = 7.2 Hz, 2H), 6.35 (s, 1H),
6.27 (s, 6H), 6.17 (s, 2H), 6.10 (br, 3H), 5.83 (s, 2H), 5.22 (s, 4H),
4.40 (br, 5H), 4.24 (br, 2H), 3.78 (br, 3H), 3.70−3.60 (m, 26H),
3.20−3.05 (m, 4H), 1.59 (s, 18H). The 13C NMR spectrum could not
be collected due to the poor solubility of 4a. MALDI MS: m/z =
−
m/z = 1009.90 [M − PF6 ]; calculated exact mass: 1154.59. Anal.
Calcd for C59H85F6N4O10P: C, 61.34; H, 7.42; N, 4.85. Found: C,
61.22; H, 7.51; N, 4.80.
Synthesis of 2a. The synthesis procedure of 2a was similar to the
1
synthesis of 1b. Yield: 0.12 g, 82%. Compound 2a: H NMR (600
MHz, CD3CN): δ ppm = 8.97 (s, 2H), 7.76 (t, J = 7.8 Hz, 1H), 7.36
(d, J = 7.8 Hz, 2H), 6.63−6.61 (m, 3H), 6.55−6.51 (m, 7H), 6.46−
6.45 (m, 3H), 6.40−6.39 (m, 7H), 6.35−6.34 (m, 2H), 6.32−6.31 (m,
2H), 6.08 (d, J = 1.8 Hz, 2H), 5.02−4.99 (m, 2H), 4.92 (d, J = 6.6 Hz,
2H), 4.59 (s, 5H), 4.45 (br, 3H), 4.04 (s, 2H), 3.94−3.93 (m, 3H),
3.85−3.84 (m, 3H), 3.76 (s, 2H), 3.73−3.68 (m, 31H), 3.65 (d, J = 3.6
Hz, 3H). 13C NMR (100 MHz, CD3CN): δ ppm = 161.5, 160.2,
147.5, 139.9, 137.2, 135.0, 122.8, 121.8, 120.2, 112.9, 110.6, 108.3,
105.9, 105,5, 103.9, 99.9, 99.2, 71.6, 71.0, 70.1, 69.5, 67.9, 55.5, 53.0,
−
1581.62 [M − PF6 ]; calculated exact mass: 1726.73. Anal. Calcd for
C101H105F6N4O13P: C, 70.21; H, 6.12; N, 3.24. Found: C, 70.29; H,
6.01; N, 3.29.
−
49.9. ESI MS: m/z = 1342.40 [M − PF6 ]; calculated exact mass:
Synthesis of 4b. The synthesis procedure of 4b was similar to that
of 4a. Yield: 37 mg, 19%. Compound 4b: 1H NMR (600 MHz,
CDCl3): δ ppm = 9.07 (s, 2H), 8.21 (d, J = 12.6 Hz, 4H), 8.03−8.00
(m, 6H), 7.96 (t, J = 4.8 Hz, 2H), 7.90−7.89 (m, 2H), 7.74 (d, J = 7.8
Hz, 2H), 6.72 (s, 1H), 6.68 (s, 1H), 6.52−6.50 (m, 4H), 6.40−6.37
(m, 4H), 6.31 (br, 5H), 6.22−6.21 (m, 2H), 6.17 (d, J = 10.8 Hz, 3H),
1486.59. Anal. Calcd for C77H89F6N4O17P: C, 62.17; H, 6.03; N, 3.77.
Found: C, 62.09; H, 6.17; N, 3.82.
Synthesis of 2b. The synthesis procedure of 2b was similar to the
1
synthesis of 1b. Yield: 0.13 g, 78%. Compound 2b: H NMR (600
MHz, CD3CN): δ ppm = 8.92 (s, 2H), 6.88 (s, 2H), 6.59−6.58 (m,
650
dx.doi.org/10.1021/jo402428y | J. Org. Chem. 2014, 79, 643−652